Akèy › Ateroskleroz › Missouri › Kansas City

Etid klinik pou Ateroskleroz nan Kansas City, MO

4 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3

Alliance for Multispecialty Research - Kansas City, Kansas City
Kansas City Veterans Affairs Medical Center, Kansas City

Laj 45 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3

Clinical Research Consultants, Kansas City
Kansas City VA Medical Center, Kansas City
DCI-Rockhill, Kansas City

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3

Research Site, Kansas City
Research Site, Kansas City

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Ap rekriteFaz 4

Kansas City VA Medical Center, Kansas City, MO, Kansas City

Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

Etid Ateroskleroz nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.